EPTQ S300 Regulatory Status: A Professional Sourcing Guide

EPTQ S300 is a hyaluronic acid dermal filler manufactured by Jetema, originating from South Korea. It is designed for professional use in aesthetic procedures. As a medical device in the aesthetic injectable category, its distribution and use are subject to strict regulatory oversight globally. Clinics and aesthetic practices must prioritize sourcing products with verified compliance credentials to uphold safety standards and legal operational frameworks.

For a hyaluronic acid dermal filler like EPTQ S300, several key certifications validate its quality and safety for professional use. The product holds KFDA approval, signifying its authorization by the South Korean Ministry of Food and Drug Safety for domestic sale and export. Additionally, EPTQ S300 is generally recognized to bear the CE Mark, which indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area.

Manufacturers like Jetema typically adhere to Good Manufacturing Practices (GMP) and possess ISO certifications, which attest to their quality management systems. It is important for professionals to note specific market approvals; for example, [VERIFY: FDA approval status for EPTQ S300 in the United States] should be independently confirmed for sourcing within the US market.

The legal status of EPTQ S300 varies across different regions, dictated by local health authorities. In the European Union and the United Kingdom, the presence of a valid CE Mark allows for market distribution, but national regulations can add further requirements. Clinics sourcing from these regions should ensure their supplier provides clear documentation of CE conformity.

For the GCC (Gulf Cooperation Council) region, products often require registration with local health ministries, building upon international certifications. Similarly, LATAM (Latin America) and APAC (Asia-Pacific) markets typically have their own national registration processes, which may necessitate specific local endorsements or import permits. Always verify regional compliance for your clinic's jurisdiction when sourcing from our Hyaluronic acid dermal filler catalog.

Professionals must be vigilant against parallel imports and grey market channels when acquiring aesthetic injectables. While parallel imports can sometimes offer lower prices, they often lack proper traceability, consistent cold chain management, and official distributor support. Products sourced outside authorized channels may carry risks such as altered packaging, compromised integrity due to improper storage, or even counterfeit formulations.

To mitigate these risks, clinics should always opt for authorized distributors who can provide full transparency regarding product origin and handling. For insights into ensuring product legitimacy, consider resources such as How to Verify Genuine Aessoa, which offers valuable guidance on authenticity checks for dermal fillers. This diligence protects your practice and patient trust.

When procuring EPTQ S300 for your clinic, demanding thorough documentation from your supplier is non-negotiable. Request manufacturer-issued Certificates of Authenticity, batch-specific lot numbers, and evidence of proper transportation and storage conditions, particularly for temperature-sensitive products. These documents are vital for ensuring product integrity and regulatory compliance. Reputable wholesalers understand this need and readily provide such assurances.

Beyond documentation, evaluate your supplier's track record and industry standing. Partnering with established distributors minimizes exposure to unauthorized or compromised products. For additional perspectives on compliant sourcing practices for injectables, review articles such as Coretox 200 Units: Regulatory Status and Professional Sourcing, which addresses similar concerns for other aesthetic products. Consider sourcing trusted brands like D.Fill Soft only through verified channels.

For professionals considering stock acquisition for their clinic, understanding the typical pricing structure for EPTQ S300 is essential for procurement planning. While actual prices vary based on regional distributors, volume, and specific contractual terms, an illustrative wholesale price point for EPTQ S300 is approximately $70.0/unit. Many suppliers offer volume-based tier discounts to support larger clinic inventories.

These tiers are designed to provide procurement efficiencies for clinics ordering in bulk. Transparent pricing structures assist clinics in managing their inventory costs effectively. Products such as Elasty Plus 1CC also often feature similar volume-based considerations.